Correlation Between T2 Biosystms and Castle Biosciences
Can any of the company-specific risk be diversified away by investing in both T2 Biosystms and Castle Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining T2 Biosystms and Castle Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between T2 Biosystms and Castle Biosciences, you can compare the effects of market volatilities on T2 Biosystms and Castle Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in T2 Biosystms with a short position of Castle Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of T2 Biosystms and Castle Biosciences.
Diversification Opportunities for T2 Biosystms and Castle Biosciences
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between TTOO and Castle is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding T2 Biosystms and Castle Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Castle Biosciences and T2 Biosystms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on T2 Biosystms are associated (or correlated) with Castle Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Castle Biosciences has no effect on the direction of T2 Biosystms i.e., T2 Biosystms and Castle Biosciences go up and down completely randomly.
Pair Corralation between T2 Biosystms and Castle Biosciences
Given the investment horizon of 90 days T2 Biosystms is expected to under-perform the Castle Biosciences. In addition to that, T2 Biosystms is 2.95 times more volatile than Castle Biosciences. It trades about -0.14 of its total potential returns per unit of risk. Castle Biosciences is currently generating about -0.16 per unit of volatility. If you would invest 3,091 in Castle Biosciences on October 8, 2024 and sell it today you would lose (230.00) from holding Castle Biosciences or give up 7.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
T2 Biosystms vs. Castle Biosciences
Performance |
Timeline |
T2 Biosystms |
Castle Biosciences |
T2 Biosystms and Castle Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with T2 Biosystms and Castle Biosciences
The main advantage of trading using opposite T2 Biosystms and Castle Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if T2 Biosystms position performs unexpectedly, Castle Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Castle Biosciences will offset losses from the drop in Castle Biosciences' long position.T2 Biosystms vs. Intelligent Bio Solutions | T2 Biosystms vs. bioAffinity Technologies, | T2 Biosystms vs. Thermo Fisher Scientific | T2 Biosystms vs. Illumina |
Castle Biosciences vs. Caredx Inc | Castle Biosciences vs. Twist Bioscience Corp | Castle Biosciences vs. Biodesix | Castle Biosciences vs. Natera Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |